A Study to Investigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabetic and Uveitic Macular Edema
Clinical trial NCT06771271 · COMPLETED
Trial details
- NCT number
- NCT06771271
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-22
- Primary completion
- 2023-11-13
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.